Biotech Trading Analyst at Chimera Research Group. Technical Analysis. Consulting & Market analysis of public companies
$MDNAF $MDNA.to We expect to provide a comprehensive data-set on monotherapy from MDNA11 dose-expansion trial And some topline data on combo trial with #Ketruda Finally Sachs shared another great presentation by Dr. Fahar, MDNA's CEO at the 10th Annual Oncology Innovation Forum!
Pleased to share another great presentation from the 10th Annual Oncology Innovation Forum. Medicenna Therapeutics Corp. presentation by Dr. Fahar Merchant, CEO Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum View Here: https://lnkd.in/dBftGMEp Press Release: https://lnkd.in/dR44hYaW #Biotech #InvestorPresentation #SachsForum #Sachs_OIF
CEO & Co-Founder at Marvel Biosciences | Capital Markets and Investment Expert | Finance and Entrepreneurship
3moExciting! And, a great story that's unfolding nicely.